PUBLISHER: The Business Research Company | PRODUCT CODE: 1946939
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946939
Pediatric perfusion serves as a critical medical mechanism responsible for circulating blood throughout a pediatric patient's body, ensuring stable blood pressure, adequate oxygen levels, and uniform distribution of blood to all bodily components.
Key pediatric perfusion products encompass pediatric cannulae, pediatric centrifugal blood pumps, pediatric arterial filters, hem concentrators, HMS plus hemostasis management systems, and pediatric oxygenators. Pediatric cannulae, small tubes inserted into a pediatric patient's vein or bodily cavities such as the nose, play a pivotal role in delivering intravenous (IV) therapy. These tools find application in various medical procedures including pediatric cardiac surgeries, organ transplantation in pediatric patients, and pediatric extracorporeal life support (ECLS). End-users such as hospitals, clinics, ambulatory surgical centers, among others, rely on these products for pediatric care.
Tariffs are impacting the pediatric perfusion market by increasing costs of imported medical-grade polymers, sensors, pumps, oxygenators, and precision-engineered components used in pediatric cannulae, blood pumps, and ECMO systems. Hospitals and pediatric cardiac centers in North America and Europe are most affected due to dependence on specialized imported devices, while Asia-Pacific faces higher procurement costs for advanced perfusion equipment. These tariffs are increasing device acquisition costs and affecting capital budgeting for pediatric care units. However, they are also encouraging localized manufacturing of perfusion disposables, regional supplier partnerships, and investment in domestic production capabilities for critical pediatric life-support systems.
The pediatric perfusion market research report is one of a series of new reports from The Business Research Company that provides pediatric perfusion market statistics, including pediatric perfusion industry global market size, regional shares, competitors with a pediatric perfusion market share, detailed pediatric perfusion market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric perfusion industry. This pediatric perfusion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric perfusion market size has grown strongly in recent years. It will grow from $2.83 billion in 2025 to $3.09 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising incidence of congenital heart defects, expansion of pediatric cardiac surgery programs, growing availability of specialized pediatric care centers, increasing survival rates in neonatal intensive care, improvements in extracorporeal circulation techniques.
The pediatric perfusion market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing investments in pediatric critical care infrastructure, rising adoption of advanced monitoring technologies, increasing focus on minimally invasive pediatric surgeries, expansion of ecmo usage in pediatric respiratory failure, continued innovation in biocompatible perfusion materials. Major trends in the forecast period include increasing adoption of miniaturized pediatric perfusion devices, rising demand for ecmo systems in neonatal care, growing integration of real-time perfusion monitoring, expansion of disposable and single-use perfusion components, enhanced focus on patient-specific perfusion solutions.
The burgeoning prevalence of cardiac congenital disorders is anticipated to propel the growth trajectory of the pediatric perfusion market in the forthcoming years. These disorders, existing at birth, significantly impact heart development and functionality, influencing blood circulation to the body's organs. Pediatric perfusion plays a pivotal role in cardiac surgeries aimed at rectifying structural heart defects, encompassing procedures such as VSD repair, ASD repair, TOF repair, coarctation of the aorta repair, among others. As of February 2023, the World Health Organization highlighted that globally, congenital diseases cause 240,000 newborn deaths within 28 days annually. Correspondingly, the CDC's January 2022 report indicated that approximately 40,000 births in the United States annually are affected by congenital cardiac abnormalities, constituting roughly 1% of the global population. This prevalence remains a driving force behind the growth of the pediatric perfusion sector.
Major companies in the pediatric perfusion market are developing advanced technologies, such as cardiopulmonary bypass (CPB) systems, to improve surgical safety and optimize clinical outcomes for infants and children. Cardiopulmonary bypass (CPB) systems are medical devices that temporarily assume the function of the heart and lungs during surgery, ensuring circulation and oxygenation while the heart is stopped. For instance, in March 2023, LivaNova, a UK-based medical devices manufacturer, introduced the Essenz Heart-Lung Machine in the US region, securing a 510(k) clearance from the U.S. Food and Drug Administration. This sophisticated perfusion system, utilized during cardiopulmonary bypass surgeries, emulates the functions of a patient's heart and lungs during open-heart procedures. Its adaptability for both adult and pediatric patients, along with its mast-mounted design ensuring minimal interference and cleanliness, showcases its effectiveness. The centralized cockpit offers a comprehensive vantage point to manage the device, monitor perfusion and patient data, and seamlessly integrate with external operating room devices and hospital information systems.
In September 2025, OrthoPediatrics Corp., a US-based orthopedic medical device company, signed a distribution agreement with MY01 Inc. to improve patient access and support its global expansion efforts. Through this collaboration, OrthoPediatrics seeks to increase availability of MY01's Continuous Perfusion Sensing Technology (CPST) Platform, facilitating early detection of acute compartment syndrome and enhancing outcomes in pediatric trauma care. MY01 Inc. is a US-based medical technology company specializing in pediatric perfusion monitoring.
Major companies operating in the pediatric perfusion market are Medtronic plc, Terumo Cardiovascular Systems Corporation, LivaNova PLC, Eurosets, Getinge AB, Edwards Lifesciences Corporation, Smiths Medical Inc., Fresenius Kabi AG, Nipro Medical Corporation, Hemovent GmbH, Spectrum Medical Ltd., Braile Biomedica, Leviticus Cardio Ltd., B. Braun Melsungen AG, Baxter International Inc., ALung Technologies Inc., Novalung GmbH, Xenios AG, Xvivo Perfusion AB, Edwards Lifesciences Corporation
North America was the largest region in the pediatric perfusion market in 2025. The regions covered in the pediatric perfusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric perfusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pediatric perfusion market consists of sales of heart-lung machines, oxygenators, blood pumps, cannulas, temperature management systems, and monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Perfusion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pediatric perfusion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric perfusion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric perfusion market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.